共 20 条
[1]
Wood D., DeBacker G., Faegerman O., Graham I., Mancia G., Pyora la K., Prevention of coronary heart disease in clinical practice. Summary of recommendations of the second joint task force of European and other societies on coronary heart prevention, Eur H J, 80, pp. 1-10, (1998)
[2]
Behandling av hyperlipidemi-rekommendationer, Information Från Läkemedelsverket, 7, pp. 15-21, (1999)
[3]
Anderson K.M., Wilson P.W.F., Odell P.M., Kannel W.B., An updated coronary risk profile. A statement for health professionals, Circulation, 83, pp. 356-362, (1991)
[4]
Backlund L., Bring J., Strender L.-E., How accurately do general practitioners and students estimate coronary risk in hypercholesterolaemic patients, Primary Health Care Research and Development, 5, pp. 145-152, (2004)
[5]
Ramachandran S., Labib M.H., Hyperlipidaemia and primary prevention of coronary heart disease: Are the right patients being treated?, J Cardiovasc Risk, 7, pp. 245-249, (2000)
[6]
Abookire S.A., Karson A.S., Fiskio J., Bates D.W., Use and monitoring of "statin" lipid-lowering drugs compared with guidelines, Arch Intern Med, 161, pp. 2626-2627, (2001)
[7]
Ericsson K.A., Simon H.A., Protocol Analysis: Verbal Reports as Data, (1984)
[8]
Backlund L., Skaner Y., Montgomery H., Bring J., Strender L.-E., Doctors' decision processes in a drug prescription task: The validity of rating scales and verbal reports, Organ Behav Hum Decis Proces, 91, pp. 108-117, (2003)
[9]
Backlund L., Skaner Y., Montgomery H., Bring J., Strender L.-E., GPs' Decisions on Drug Treatment for Patients with High Cholesterol Values: A Think-Aloud Study
[10]
Axelrod R., The analysis of cognitive maps, Structure of Decision, pp. 55-73, (1976)